Days Inventory is also known as Days Sales of Inventory (DSI). Vertex Pharmaceuticals's Average Total Inventories for the
three
months ended in Dec. 2023 was $714 Mil. Vertex Pharmaceuticals's Cost of Goods Sold for the
three
months ended in Dec. 2023 was $368 Mil.
Hence, Vertex Pharmaceuticals's Days Inventory for the
three
months ended in Dec. 2023 was 176.98.
The historical rank and industry rank for Vertex Pharmaceuticals's Days Inventory or its related term are showing as below:
VRTX'
s Days Inventory Range Over the Past 10 Years
Min: 97.23 Med: 126.8 Max: 175.05
Current: 175.05
During the past 13 years, Vertex Pharmaceuticals's highest Days Inventory was 175.05. The lowest was 97.23. And the median was 126.80.
VRTX's Days Inventory is ranked better than 53.31% of 649
companies
in the Biotechnology industry
Industry Median: 192.13
vs VRTX: 175.05
Vertex Pharmaceuticals's Days Inventory
increased
from Dec. 2022 (136.70) to Dec. 2023 (176.98).
It might indicate that Vertex Pharmaceuticals's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Vertex Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 was 0.52.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vertex Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Dec. 2023 was 0.28.
Vertex Pharmaceuticals Days Inventory Historical Data
The historical data trend for Vertex Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Vertex Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vertex Pharmaceuticals Days Inventory Distribution
For the Biotechnology industry and Healthcare sector, Vertex Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Vertex Pharmaceuticals's Days Inventory falls into.
Vertex Pharmaceuticals Days Inventory Calculation
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
Vertex Pharmaceuticals's Days Inventory for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vertex Pharmaceuticals (NAS:VRTX) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Vertex Pharmaceuticals's Inventory Turnover for the
three
months ended in Dec. 2023 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Vertex Pharmaceuticals's Inventory to Revenue for the
three
months ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Vertex Pharmaceuticals Days Inventory Related Terms
Thank you for viewing the detailed overview of Vertex Pharmaceuticals's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.
Vertex Pharmaceuticals (Vertex Pharmaceuticals) Business Description
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using nonopioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VRTX has been successfully added to your 